Optimal unbiased tests for equivalence in intrasubject variability

Journal of the American Statistical Association

Volumn 92, Issue 439, 1997, Pages 1163-1170

  Wang, Weizhen ^a  

^a WRIGHT STATE UNIVERSITY   (United States)

Author keywords

Cross over design; Linear regression; Two one sided tests procedure; Uniformly most powerful invariant test

Indexed keywords

EID: 21744458372     PISSN: 01621459     EISSN: 1537274X     Source Type: Journal    
DOI: 10.1080/01621459.1997.10474073     Document Type: Article

References (7)

1. Anderson, S., and Hauck, W. W.(1990), "Consideration of Individual Bioequivalence,"Journal of Pharmacokinetics and Biopharmaceutics,18, 259-273.
2. Brown, L. D., Hwang, J. T. G., and Munk, A.(1997), "An Unbiased Test for the Bioequivalence Problem," submitted to Annals of Statistics.
3. Lehmann, E. T.(1986), Testing Statistical Hypotheses (2nd ed.), New York: Wiley.
4. Liu, J. P., and Chow, S. C.(1992), "On Assessment of Bioequivalence in Variability of Bioavailability Studies,"Communications in Statistics, Part A-Theory and Methods, 21, 2591-2607.
5. Schuirmann, D. J.(1987), "A Comparison of the Two One-Sided Tests Procedure and the Power Approach for Assessing the Equivalence of Average Bioavailability,"Journal of Pharmacokinetics and Biopharmaceutics, 15, 657-680.
6. U.S.Food and DrugAdministration(1992), "FDA Guidance on Statistical Procedures for Bioequivalence Studies Using a Standard Two-Treatment Crossover Design,"Division of Bioequivalence, Of fice of Generic Drugs, Center for Drug Evaluation and Research, U. S. Food and Drug Administration, Rockville, MD.
7. Wang, W.(1995), "On Assessment of Bioequivalence," Ph. D. thesis, Cornell University.